Navigation Links
First Patients Enrolled in Phase II Trial With Intravenous Iclaprim in HAP/VAP/HCAP
Date:12/12/2007

data-sets have been transferred and the authorities have confirmed the receipt and navigability of the information. Both the rolling NDA and the electronic format could greatly facilitate the review process.

The first modules of the NDA package are ready and will be filed before year-end 2007. The remaining modules are expected to be transferred and filing is forecast to be completed by the end of February 2008.

Dr Khalid Islam, President and CEO of Arpida Ltd., commented: "We are pleased with the progress made across the several different programmes.

Firstly, initiation of patient enrolment in the Phase II trial with intravenous iclaprim in HAP/VAP/HCAP provides a good basis for the completion of the trial within the planned timelines. HAP/VAP/HCAP is a serious, life-threatening condition with a high medical need. We believe that iclaprim could have a high potential in this indication based on its potent and bactericidal action on MRSA and its good distribution in those lung compartments where the key respiratory pathogens reside."

Dr Islam added: "Moreover, we are very pleased with the results of the ascending dose trial with oral iclaprim, which show a good tolerability at high doses. We are now working to complete the Phase I programme while at the same time discussing with the regulatory authorities regarding the potential next steps in the development path of oral iclaprim.

Work on the NDA for intravenous iclaprim in cSSSI is progressing well. We expect to file the first modules of the package before year-end and complete the filing by the end of February 2008. After finalising the NDA filing, our next steps will focus on the preparation of the commercial launch of iclaprim."

Conference Call

Arpida will host a conference call to discuss these recent developments, today, 11 December 2007, at 3 pm CET. The dial-in numbers are:

+41-(0)91-610-56-00 (Europe)

+44-(0)207-107-06-11 (UK)

+1-(1)866-29
'/>"/>

SOURCE Arpida Ltd
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5

Related biology technology :

1. Reclast(R) Receives US FDA Approval as First and Only Once-Yearly Treatment for Women With Postmenopausal Osteoporosis
2. GlaxoSmithKline Recognizes University of Michigans Dr. Daniel F. Hayes as the First Recipient of the Gianni Bonadonna Breast Cancer Award
3. Kewaunee Scientific Announces First Quarter Results and Quarterly Dividend
4. Genmab Announces 2007 First Half Year Results
5. Pharsight Achieves First License Sale for Public-Source Database
6. Novare Announces First Ever Single Port Laparoscopic Kidney Removal (Nephrectomy) Using RealHand(TM) HD Instruments
7. ExonHit Therapeutics: Allergan and ExonHits First Collaboration Compound to Begin Human Clinical Trials
8. China Medical Technologies Reports First Quarter Financial Results
9. Pressure BioSciences, Inc. Issued First Patent in Canada
10. Peregrine Pharmaceuticals to Announce First Quarter FY 2008 Financial Results
11. Exelixis Reports Encouraging Interim Data From a Phase 2 Trial of XL647 as First-Line Therapy for Non-Small Cell Lung Cancer

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/19/2009)...NSTER, Germany, November 19 MONITO...November 16th, 2009 Flibanserin in the,indication ...Parkinson,s,disease for orphan drug status designa...vodopa-induced dyskinesia is a complication of the...serious burden to some of those,affected, since it...
(Date:11/19/2009)... InSound is honored by latest award for revol...ewark, CA (PRWEB) November 16, 2009 -- Popular Sci...” hearing aid from InSound Medical a winner ...he Health category.    Chosen ...eside deep in the hearing canal for up to four mon...
(Date:11/18/2009)...nnel need to be able to find explosive materials a...aid such searches, the National Institute of Stand...Department of Homeland Security, has developed a n...e Material (SRM) 2905, Trace Particulate Explosive...ods, the SRM will be helpful in calibrating, testi...
(Date:11/18/2009)...r,s experience in data analysis combined with Bio-... kits and curricula provide state-of-the-art so...ON, Ore., Nov. 18 Vernier Software...ce interfaces, sensors, and software and Bio-Rad L...d distributor of life science research and clinica...
Breaking Biology Technology:MONITORING FORCE GmbH Requests Acknowledgment of Flibanserin as "Orphan Drug" 2Popular Science Awards Lyric “Invisible” Hearing Aid 2009 “Best of What's New” Award 2Popular Science Awards Lyric “Invisible” Hearing Aid 2009 “Best of What's New” Award 3New NIST trace explosives standard slated for homeland security duty 2Vernier and Bio-Rad to Offer Enhanced Solutions for Biotechnology Education 2
... Sept. 18 Ingenuity Systems, the,leading provider...cientific,literature and data, is pleased to annou... major public-private biomedical research,partners...biological,markers to support new drug development...he founding members of the Consortium include the ...
...er 18 - Clinical Study Demonstrates Breakthrough... Capacities and Expands Potential Production,Capac... Sanofi pasteur, the vaccines division of sanofi-...ts new investigational H5N1 pandemic influenza,vac...high immune response,at the lowest dose of H5N1 an...
...e University of Pennsylvania have developed nanowi...ears and retrieving that data a thousand times fas...Flash memory and micro-drives, all using less powe...tesh Agarwal, an assistant professor in the Depart...leagues developed a self-assembling nanowire of ge...
Other Biology Technology:Ingenuity Systems Joins Biomarkers Consortium 2Sanofi Pasteur's Investigational H5N1 Influenza Vaccine Achieves High Immune Response at low Dosage 2Sanofi Pasteur's Investigational H5N1 Influenza Vaccine Achieves High Immune Response at low Dosage 3Sanofi Pasteur's Investigational H5N1 Influenza Vaccine Achieves High Immune Response at low Dosage 4Sanofi Pasteur's Investigational H5N1 Influenza Vaccine Achieves High Immune Response at low Dosage 5Penn engineers design computer memory in nanoscale form that retrieves data 1,000 times faster 2Penn engineers design computer memory in nanoscale form that retrieves data 1,000 times faster 3
(Date:11/20/2009)...h 2009 - Bacteria possess an ingenious mechanism f...cks of the cell. This is the new finding of a team... a life sciences research institute in Flanders, B...l. The scientists made this discovery by modifying...coli . By means of this model organism, they have ...
(Date:11/20/2009)...ulmonary disease (COPD), a respiratory disease com... the fourth leading cause of death worldwide. 600...rs have yet to find any real treatment or cure, Gr...niversity of Western Ontario in London, Canada, is...ght into the disease. , Parraga is a scienti...
(Date:11/19/2009)...rring brain chemical with an unwieldy name: 4-hydr...ed or used as a date-rape drug. , Now, a team o... routes by which 4-HB is metabolized by the body. ...ichael Gibson, professor and chair of biological s... member of the research team. "It may provide new...
Breaking Biology News(10 mins):Biologists discover bacterial defense mechanism against aggressive oxygen 2Gaining a better picture of lung disease 2Researchers begin to decipher metabolism of sexual assault drug 2Adam Kluger Public Relations Adds Sex Therapist and Psychiatrist Dr Dennis Lin MD to Their All Star Health and Medical Client Roster 60057 1Adam Kluger Public Relations Adds Sex Therapist and Psychiatrist Dr Dennis Lin MD to Their All Star Health and Medical Client Roster 60057 2AMERIGROUP Announces Preliminary Third Quarter Results 60054 1AMERIGROUP Announces Preliminary Third Quarter Results 60054 2AMERIGROUP Announces Preliminary Third Quarter Results 60054 3AMERIGROUP Announces Preliminary Third Quarter Results 60054 4AMERIGROUP Announces Preliminary Third Quarter Results 60054 5Insure com Inc Announces Name Change to Life Quotes Inc and Nasdaq Ticker Symbol Change to QUOT Effective October 28 2009 60051 1Insure com Inc Announces Name Change to Life Quotes Inc and Nasdaq Ticker Symbol Change to QUOT Effective October 28 2009 60051 2
...ntain codeine may be risky for some,breastfeeding ...y of Western Ontario, and the Hospital for Sick Ch...on Koren published research in the journal, Clini...at the codeine used in some pain relief drugs can ...nfants when ingested by some breastfeeding mothers...
...genetic code of a simple saltwater creature could ...nes function in humans and other species. , A stu...aks down the genetic code of Trichoplax , a simpl...in the world, even in the common household aquariu...x , genes that are also found in other animals - o...
...ide algae, Karenia brevis, costs approximately $20...t of Florida alone. Scientists at the Georgia Inst...educe the levels of the red tide,s toxicity to ani...s toxicity to other algae as well. If scientists c...y of red tide, they could reduce the vast amount o...
Other Biology News:Codeine not safe for all breastfeeding moms and their babies 2Genome of saltwater creature could aid understanding of gene grouping 2Biologists find diatom to reduce red tide's toxicity 2Biologists find diatom to reduce red tide's toxicity 3
...ou need a partner who can put you on the fast trac... solutions to help accelerate your research. Thats...tion offers a liquid handling platform thats as ad...ts of liquid handling into a single, automated sys...
...0 rabbit tissue samples arrayed on Superfrost Plus...ned slides and 1 hematoxylin and eosin (H&E) stain...5 different tissues from 4 rabbit organisms, for a... sample (or core) is 1.5 mm in diameter. The type ...
...with a wide variety of purity levels, scales and m...rity: IG(>50%), >70%, >80% and >95% Yield: 2mg...ications: Biotin, Fluorescein, N-acetylation, C-a...H/BSA conjugation, and much more. See Modificatio...
Human CALCA EIA (Enzyme immunoassay) Kit, Host: Rabbit ; Extraction-free from BACHEM
Biology Products: